Previous Close
$2.59
Day Range
$0 - $0
Previous Day Range
$2.55 - $2.8
Market Cap
$8.6 million USD
Day Vol.
0
Previous Day Vol.
94026
Currency
USD
Primary Exchange
Nasdaq
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view